PegIntron.com Home
PegIntron.com Home

Why PEG-INTRON®?

You may be surprised to learn that only about 15% of people with hepatitis C are able to fight off the infection without treatment. If you're among the other 85% it's likely that you'll need some form of therapy to regain your health. While several aspects of your infection will affect how treatment will help, the amount of hepatitis C virus in your blood is important in determining whether or not treatment will help you.

PEG-INTRON® combination therapy has been proven to be more effective than standard non-pegylated interferon in treating chronic hepatitis C. That means PEG-INTRON® combination therapy provides you with a better chance of clearing the virus from your body.

This section explains why the current treatment recommended by the National Institutes of Health for chronic hepatitis C is pegylated alpha interferons and why you should consider choosing a pegylated interferon like PEG-INTRON®.

Start Strong, Finish Strong.

PEG-INTRON® therapy has been prescribed to more than 230,000 patients diagnosed with hepatitis C. Find out why.

How PEG-INTRON® Works

Learn why pegylated interferon - like PEG-INTRON® combination therapy - stay in your body longer that non-pegylated interferons, and why this is so important to the outcome of your treatment.

Overview of the PEG-INTRON® REDIPEN®

Find out why 80% of patients surveyed said that the PEG-INTRON® REDIPEN® gives them the features they want in an injection system1.

Features of the PEG-INTRON® REDIPEN®

The PEG-INTRON® REDIPEN® is designed to be patient-friendly. Learn more about its features and packaging.

How To Use the PEG-INTRON® REDIPEN®

Read about the basic steps involved in preparing and injecting the PEG-INTRON® REDIPEN® dose.

How To Use the PEG-INTRON® REDIPEN® (Video)

View this video to see a detailed demonstration of each step of the medication administration process.

Key Facts About the PEG-INTRON® REDIPEN®

Still not convinced about the benefits of PEG-INTRON®? Get answers to some common questions here.

1 Data on file, Schering Corporation.